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Abstract
Background: IgE recognition of panallergens having highly conserved sequence regions, structure, and function and shared
by inhalant and food allergen sources is often observed.
Methods: We evaluated the IgE recognition profile of profilins (Bet v 2, Cyn d 12, Hel a 2, Hev b 8, Mer a 1, Ole e 2, Par j 3, Phl
p 12, Pho d 2), PR-10 proteins (Aln g 1, Api g 1, Bet v 1.0101, Bet v 1.0401, Cor a 1, Dau c 1 and Mal d 1.0108) and
tropomyosins (Ani s 3, Der p 10, Hel as 1, Pen i 1, Pen m 1, Per a 7) using the Immuno-Solid phase Allergen Chip (ISAC)
microarray system. The three panallergen groups were well represented among the allergenic molecules immobilized on
the ISAC. Moreover, they are distributed in several taxonomical allergenic sources, either close or distant, and have a route
of exposure being either inhalation or ingestion.
Results: 3,113 individuals (49.9% female) were selected on the basis of their reactivity to profilins, PR-10 or tropomyosins.
1,521 (48.8%) patients were reactive to profilins (77.6% Mer a 1 IgE
+), 1,420 (45.6%) to PR-10 (92.5% Bet v 1 IgE
+) and 632
(20.3%) to tropomyosins (68% Der p 10 IgE
+). A significant direct relationship between different representative molecules
within each group of panallergens was found. 2,688 patients (86.4%) recognized only one out of the three distinct groups of
molecules as confirmed also by hierarchical clustering analysis.
Conclusions: Unless exposed to most of the allergens in the same or related allergenic sources, a preferential IgE response
to distinct panallergens has been recorded. Allergen microarray IgE testing increases our knowledge of the IgE immune
response and related epidemiological features within and between homologous molecules better describing the patients’
immunological phenotypes.
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Introduction
The prevalence of allergic diseases has dramatically increased in
last decades, mostly in developed countries [1,2]. Comprehensive
and reliable allergy diagnostic testing are needed, also for
therapeutic decision making [3]. In vitro diagnosis of allergic
sensitizations is based on the measurement of specific IgE in sera of
allergic patients [4]. Most of the currently available singleplex in
vitro assays measure the IgE reactivity to extracts obtained from
raw material derived from several organisms or their tissues. No
information about the number of molecules involved or about the
molecular profile associated with a given clinical manifestation is
currently provided by extract-based testing.
A major problem is represented by the possibility that positive
results, employing extracts, could be caused by IgE recognition of
homologous molecules instead of molecules that represent the
genuine marker of sensitization to a given biological source [5]. In
the past 10 years the production of highly purified natural or
recombinant allergens together with the recent advances in
microarray technology provided the background for the develop-
ment of a multiplexed assay as efficient means to test IgE
sensitization to hundreds of allergenic molecules simultaneously in
large populations [6–8].
Adverse reactions after the ingestion of animal- or plant-derived
foods caused by IgE cross-reactive molecules shared by inhalant
and food allergen sources are often seen in clinical practice [9].
These molecules are commonly defined as ‘‘pan-allergens’’ and
represent families of homologous and structurally related proteins
belonging to different biological sources (i.e. profilins, PR-10
molecules, tropomyosins) [10–12]. As the three molecule groups
considered in the present study have different distributions in
nature, namely profilins are ubiquitous eukaryotic proteins, found
in both animal and plant sources, tropomyosins are highly
conserved eukaryotic proteins, but are not found in plants, and
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definition has been herein used to identify allergenic molecules
belonging to distant genera/orders rather than because they span
across kingdoms. Profilins are actin-binding proteins having a
molecular weight between 12–15 kDa, and present in the cell
cytoplasm. They have been described as allergens in pollen sources
and plant-derived food. Up to now 100 profilins have been
described as allergenic, 55 of them in pollen from distant
taxonomical species. PR-10 belong to the pathogenesis-related
protein groups. They are molecules having a molecular weight of
16–18 kDa, produced in response to biotic and abiotic stresses,
and described as allergens in pollen and plant-derived foods. Fifty
three PR-10 have been described up to now, 17 from pollen of the
Fagales order, whereas homologous from foods, like apple, carrot,
celery, kiwi, are from quite distant taxonomical species. Tropo-
myosins are animal structural muscle proteins with a molecular
weight of about 35 kDa. Tropomyosins are well described food
allergens from crustaceans, but homologous allergens are found in
arthropods not commonly used as food, like mites and cockroach-
es, causing allergic diseases by the inhalation route. Up to now 93
tropomyosins have been described as allergenic, 77 from
shellfishes. All data on panallergens have been retrieved from
Allergome (www.allergome.org), accessed April 30, 2011. This
web-based platform can be used for more detailed and up to date
descriptions of each allergen reported in the present study.
The aim of our study was to bring a further and more in deep
insight into the distribution of the IgE reactivity to three
panallergen groups (profilins, PR-10 and tropomyosins) in 3,113
individuals with a history of food allergy, rhinitis, asthma or atopic
dermatitis, either looking at the reciprocal IgE positivity of each
group compared to the others, or within each of the three
panallergen groups. The study population is from Italy, extracted
from a reported study [7], and being exposed and sensitized to the
three groups of molecules. We selected these three groups of
panallergens because they are well represented among the
allergenic molecules immobilized on the available microarray
version, and because they are distributed in several taxonomical
allergenic sources, either close or distant, and having a route of
exposure being either inhalation or ingestion. Thus, these three
molecule groups have the highest probability to get in contact with
the human immune system, though variable exposure levels could
occur, largely depending on inhalant allergen seasonality, spatial
(geographical) distributions, or frequency and amount of ingested
food items.
Methods
Ethics Statement
The study was approved by the Institutional Review Board of
Istituto Dermopatico dell’Immacolata – IDI-IRCCS, Rome, Italy
Table 1. List, characteristics, and Allergome reference code for the three panallergen groups, ranked by prevalence of IgE
reactivity among and within groups.
Panallergens IgE Reactive Patients
Allergen Common name
Allergome
Code
Molecule Sequence
Identity6 N. % N. %
Mer a 1 Profilin 476 100 1,521 48.8 1181 77.6
Hev b 8 397 81 1019 67.0
Bet v 2 127 84 986 64.8
Ole e 2* 490 85 977 64.2
Hel a 2 377 75 889 58.4
Pho d 2 571 80 876 57.6
Cyn d 12 279 76 857 56.3
Par j 3 510 78 688 45.2
Phl p 12 553 82 551 36.2
Bet v 1 PR-10 89 100 1,420 45.6 1314 92.5
Cor a 1 232 83 960 67.6
Aln g 1 7 81 741 52.2
Mal d 1 464 65 696 49.0
Api g 1 40 41 163 11.5
Dau c 1 287 39 59 4.2
Der p 10 Tropomyosin 311 100 632 20.3 430 68.0
Pen i 1* 527 <80
# 326 51.6
Pen m 1* 872 80 313 49.5
Ani s 3 37 73 313 49.5
Hel as 1 378 64 309 48.9
Per a 7 542 79 272 43.0
*Natural purified molecules, all others are E.coli-produced recombinants. Biochemical, immunological and clinical details on each allergen are available at www.
allergome.org.
uGenerated using AllergomeAligner (www.allergome.org) assuming the first ranked IgE reactive allergen as reference sequence (=100%).
#Complete Pen i 1 sequence is not available. From peptide fragment matching and IgE reactivity it is assumed to be close to Pen m 1.
doi:10.1371/journal.pone.0024912.t001
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the study is based on the oral informed consent for blood sampling
obtained from patients or caregivers during the allergy consult, as
IgE detection by microarray testing was part of the routine
procedures in each patient diagnostic work-up. All patients, being
informed by the specialist performing demographic and clinical
data collection and suggesting them the IgE testing as reported in
the present study, approved the study itself.
Study population
Data herein reported have been extracted and further analyzed
from the total of 23,077 subjects previously reported by us [7].
Briefly, unselected consecutive subjects, 61.2% female; age range
between 1 and 98 years old, referred for a history of food allergy,
rhinitis, asthma, atopic dermatitis, latex allergy, acute or chronic
urticaria to the Center for Molecular Allergology (IDI-IRCCS,
Rome, Italy) from March 2006 to December 2007 [7].
Demographical (age and gender) and clinical (respiratory and
food ingestion-related symptoms) data were recorded for all
patients at history taking by means of the InterAll software for
clinical data recording (InterAll version 3.0, Allergy Data
Laboratories s.c., Latina, Italy) [13].
Three thousand, one hundred and thirteen individuals (49.9%
female; age range between 2 and 96 years old) were selected on the
basis of their IgE reactivity detected using the Immuno-Solid
phase Allergen Chip (ISAC) system (VBC-Genomics, Vienna,
Austria). Candidates had to be IgE positive to at least one allergen
of the following group of panallergens: profilins (Bet v 2, Cyn d 12,
Hel a 2, Hev b 8, Mer a 1, Ole e 2, Par j 3, Phl p 12, Pho d 2); PR-
10 (Aln g 1, Api g 1, Bet v 1.0101, Bet v 1.0401, Cor a 1, Dau c 1
and Mal d 1.0108); tropomyosins (Ani s 3, Der p 10, Hel as 1, Pen
i 1, Pen m 1, Per a 7). Selected subjects thus acted as our study
group.
Purified natural and recombinant allergens
Table 1 reports the characteristics of the recombinant and
natural allergenic molecules listed above and used for the IgE
microarray testing in this study. All the molecules studied were
recombinant allergens expressed in Escherichia coli, with the
exception of Ole e 2, Pen m 1, Pen i 1, which were naturally
purified preparations. Table 1 displays the Allergome code
(Allergen ID) for each molecule. Further details on single molecule
characteristics are available via the Allergome web site (www.
allergome.org) [13].
Proteomic Allergen Microarray IgE Testing
IgE microarray assay. Glass microscopy slides, each
bearing four reaction sites bearing immobilized allergens, as
provided by the manufacturer (VBC-Genomics), were washed for
60 min in TBS-T buffer (150 mM sodium chloride, 10 mM Tris
base, and 0.5% Tween 20, pH 8.0), rinsed with deionised water,
and dried. Slides were placed into a humid chamber and 20 mlo f
undiluted serum from each patient was applied to the reaction site.
After incubation with patient’s sera for 120 min at R.T., slides
were rinsed and washed for 15 min in TBS-T, for 5 min in
deionised water and dried. To detect bound IgE antibodies,
allergen chips were incubated for 60 min at room temperature
with 20 ml of an Alexa Fluor 546 fluorescence-labeled (Alexa Fluor
546 protein labeling kit, Molecular Probes, Leiden, Netherlands)
anti-human IgE antibody (Pharmingen, San Diego, CA) diluted
1:1000 in TBS-T containing 5% milk powder. Afterwards, slides
were washed twice for 10 min with TBS-T, rinsed with deionised
water, dried, and stored in the dark until scanning.
Image and data acquisition, and quantification of
IgE. Images were acquired by scanning allergen chips with a
ScanArray Gx Microarray Analysis System (Perkin Elmer Life and
Analytical Sciences, Shelton, CT) with two different laser power
settings. In the first scan, 70% of the laser power (50 db) was
employed to obtain the highest possible signal intensities with
acceptable background noise. In a second scanning step, laser
power was reduced to 35 db in order to prevent saturated signals
(65.535). Both images of each spot were analyzed using the
ScanArray Express 3.0 software (PerkinElmer). Captured images
saved as a TIFF file were imported into the ISAC software (VBC-
Genomics) which specifically process the raw fluorescence value
expressed as fluorescence index of each spot. From the three
fluorescence values obtained for each allergen on triplicate spots,
the mean value was calculated and used for further analysis. IgE
values were expressed as kUA/l by interpolating the mean
fluorescence value with a previously established reference curve
[14–16]. At the end of each run data were exported to the InterAll
software by a real-time connectivity, and saved in the patient’s
record where demographical and clinical data were saved earlier
by the allergy specialist.
Though several ISAC biochips with different number of spotted
allergens have been used during the study timeframe (ISAC79,
ISAC81, ISAC86), we analyzed results from the 23 homologous
molecules immobilized on all of them. For comparative purposes
we used results available the same microarray testing for Phl p 1,
Par j 2, and Der p 1, all considered genuine markers of
sensitization to grass and parietaria pollen, and to house dust
mite, respectively. The only route of exposure for all the selected
genuine allergens is inhalation.
Clustering analysis and Statistical evaluation
To verify the molecule IgE recognition profiles, we took
advantage of the Genesis software version 1.7.2, originally
developed for cluster analysis of genomics data [17]. The software
has been adapted to be applied to proteomics of specific IgE
detected by means of the ISAC molecule-based microarray.
Relatedness of IgE recognition profiles was tested by applying
unsupervised Eisen’s hierarchical cluster methods [18] to the data
set, encompassing allergenic molecules across all samples and
Figure 1. Age group distribution of the ISAC IgE panallergens-
reactive population; n=3,113. Black bars: Total 23,077 original
allergic population; White Bars: Total 3,113 panallergens allergic
population; Dark grey bars: PR-10; Hatched bars: Profilin; Light grey
bars: Tropomyosin.
doi:10.1371/journal.pone.0024912.g001
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implemented in the Genesis software [17]. Unsupervised clustering
involved the sorting of both homologous allergenic molecules and
IgE recognition values. The IgE recognition tree was computed on
the basis of a full data set and the distance between samples were
computed by using Pearson correlation as similarity measures.
Molecular allergens with a similar pattern of IgE recognition were
grouped as hierarchical clusters and presented as heat-maps [7].
Each square in the heat-map represent the presence (red) or the
absence (black) of IgE recognition of any given tested allergens for
each tested subject. The red color intensity of every single square
in the heat-map is directly associated with the measured IgE
concentration. Interpretation of the heat-map generated by the
software can be done either visually, where clustering IgE positive
allergens tends to give more homogeneous red areas, or by taking
into consideration the higher or lower level of dendrograms on
allergen side of the graph.
Data collected in the InterAll database were also analyzed using
the SPSS/PC + statistical package (SPSS, version 15, Chicago, IL).
The levels of the variables of interest in the serum (IgE) from
allergic patients were summarized showing the mean 6 SD, in
order to provide the most easily interpretable summary measure.
However, differences between the levels of these variables were
also tested using the nonparametric Mann–Whitney U-test. The
degree of relationship between the quantitative variables studied
was analyzed using Pearson Correlation test (r). Chi-square test
has been used for prevalence comparisons. Statistical significance
cut-off level has been set for p,0.01.
Results
Descriptive statistics
A total of 3,113 subjects (49.9% female), showing an IgE
reactivity to at least one molecule belonging to profilin, PR-10,
and tropomyosin allergen groups, represented our study group.
The median age was 30.8617.04 years, but male subjects were
significantly younger (28.3617.5 vs 30.4616.1, Mann-Whitney
Rank Sum Test p ,0.0001). No major differences were recorded
comparing to the median age of the entire studied population
(30.8618.3 years), whilst the gender distribution was different
when compared to the original general population (55.2% female)
from which our study group was extracted.
As shown in Table 1, profilin reactive individuals represented
the largest group of patients, whilst tropomyosin reactive patients
were the smaller one. Interestingly, PR-10 reactive individuals
were prevalently female (Pearson x
2 test 4.8 p=0.027), whereas
the opposite was observed in the case of tropomyosin reactivity (x
2
test 5.36 p,0.021). A slight, not significant, prevalence of male
population (51.4%) was observed in profilin reactive patients, as
well. Unless profilin sequence identity were above 75%, IgE
recognition ranked between 76.6% and 36.2%. A broader
Figure 2. Venn diagram comparative representations of the IgE
reactivity distributions. Panel A: Venn diagram of IgE reactivity
distributions of the three panallergen groups, profilins, PR-10, and
tropomyosin (n=3,113); Panel B: Venn diagram of IgE reactivity
distributions of genuine inhalant allergens Phl p 1, Der p 1, and
including Bet v 1 when considered as a marker of genuine pollen
sensitization; Panel C: Venn diagram of IgE reactivity distributions of
exclusive genuine inhalant allergens Phl p 1, Der p 1, and Par j 2; Panel
D: Statistical comparative evaluations of concurrent IgE reactivity to 1, 2,
3, or 2 and 3 groups in Venn diagrams shown in panel A (dark grey
hatched bars), panel B (light grey horizontal line bars), panel C (white
vertical line bars).
doi:10.1371/journal.pone.0024912.g002
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Dau c 1 (39%) the lowest sequence identity value. IgE prevalence
was the broadest as well, ranging between 92.5% and 4.2%.
Tropomyosins behaved as profilins, having the lowest sequence
identity above 64%, but IgE prevalence ranged between 68% and
43%.
The panallergens IgE-positive cohort has been divided in eight
consecutive age groups (Figure 1). Patients younger than 5 years
old mainly recognized tropomyosin molecules, whilst the IgE
profilin-reactive population was more prevalent between patients
aged 6 to 45 years old. The prevalence of IgE reactivity to PR-10
molecules was the top ranked in patients older than 46.
Two thousand, six hundred and eighty-eight patients (86.4%)
recognized just one out of the three distinct groups of panallergens,
with a preferential recognition behavior (Figure 2, Panel A). Four
hundred and twenty-four (13.6%) individuals had IgE to more
than one panallergen group, but, among them, only 36 individuals
(1.2%) recognized molecules belonging to all the three panallergen
groups (Figure 2, Panel A). Among patients having IgE
recognizing more than one panallergen group, 270 individuals
(8.7%) had IgE to PR-10 and profilin molecules, 73 (2.3%) to
tropomyosin and profilin, and 45 (1.4%) to tropomyosin and PR-
10 panallergens (Figure 2, Panel A). To verify whether such
distribution was related to any bias present in the patient
recruitment phase or was related to any specific allergen
sensitization process, data available for genuine allergen IgE
testing were analyzed as reported in Figure 2 panel B and C.
Concurrent sensitization to 2 or 3 genuine allergens was recorded
with a statistically significant difference when compared to the
distribution recorded for panallergens.
Bivariate Correlation within Panallergen Groups
The association among the different molecules studied without
distinction between independent and dependent variables was
analyzed using the Pearson Correlation test. As shown in Figure 3,
a significant direct relationship of IgE recognition of profilin, PR-
10, and tropomyosin molecules, respectively, was recorded
(p,0.001). Every single molecule belonging to a given group of
panallergens, therefore, showed similar behavior of IgE recogni-
tion. In the case of PR-10 molecules, regardless the presence of a
significant association between all molecules, the Pearson
correlation coefficients analysis revealed a strong relationship
(Pearson Correlation from 0.70 to 1) between Bet v 1, Aln g 1 and
Cor a 1 from one side and between Api g 1 and Dau c 1 from the
other, thus suggesting the presence of a distinct patterns of IgE
recognition between PR-10 molecules belonging to inhalant and
food allergens, respectively.
In the case of profilin and tropomyosin molecules, all the
Pearson correlation coefficient resulted to be higher than 0.70,
thus confirming a strong structural and immunological relation-
ship between the tested molecules.
Cluster analysis
Supervised two-way hierarchical clustering analysis, sorting for
both allergenic molecules and IgE recognition values, generated
distinct clusters of IgE recognition of profilin, PR-10, and
Figure 3. Bivariate analysis of reciprocal relationships of IgE to
profilin, PR-10, and tropomyosin panallergens. The number of
IgE reactive subjects and the Pearson coefficient are shown for paired
allergens within the three panallergen groups. Pearson r values are
reported below. Data were statistically significant in all cases (p,0.001).
Panel A: Profilins; Panel B: PR-10; Panel C: Tropomyosins.
doi:10.1371/journal.pone.0024912.g003
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of these three distinct groups of molecules was exclusive in 86.4%
of cases, as already mentioned, and also the clustering analysis
confirmed the high level of exclusivity of IgE recognition of the
three panallergens herein evaluated. Plant derived panallergens
(PR-10 and profilin molecules) generated a larger cluster of
reactivity distinct from the one generated by tropomyosin
molecules. In the case of PR-10 molecules, two distinct clusters
of IgE reactivity (between Api g 1 and Dau c 1 the first and
between Bet v 1, Cor a 1 and Aln g 1 the second) were recorded.
Also in the case of tropomyosin IgE reactivity, we observed two
distinct clusters of reactivity: one shaped by Hel as 1 and Per a 7,
the other by Ani s 3, Der p 10, Pen i 1 and Pen m 1, respectively.
Discussion
In the present study we perform an in deep analysis of the
prevalence of IgE reactivity to panallergens in a large cohort of
allergic patients, evaluated by means of a microarray IgE detection
system. We studied three groups of molecules belonging to
different biological sources and tissues (profilin, PR-10, and
tropomyosin), involved at the same time in respiratory and food
allergy. Such allergens have been reported as representative
examples of IgE ‘‘cross reactivity’’ between otherwise unrelated
organisms [19–26].
We found that panallergen IgE recognition is exclusive in a
large part of our Italian cohort. More than 86% of patients
produce specific IgE to a group of panallergens but not to the
others. As a result, in the vast majority of cases, the multiple
reactivity to inhalant or food allergenic sources was caused by the
sensitization to at least one representative molecule of a single
panallergen group. Similarly, tropomyosin reactive individuals did
not raise an IgE response to other panallergens, as also shown by
the hierarchical clustering analysis (Figure 4). Comparatively we
showed that when allergenic molecules sensitizing allergic patients
by the inhalation route are considered a significant number of
concurrent sensitization is recorded. Such number is higher when
the exclusive inhalation route of sensitization and the following
exposure is considered.
The use of the same approach, originally designed for genomic
evaluation, in the epidemiological assessment of IgE reactivity to
panallergens, might help in the management of large amount of
data generated by serial proteomic evaluation of hundreds of
molecules at the same time, in the same group of patients [7]. In
this way, it is possible to identify subsets of patients having a
similar IgE recognition profile. At the same time, it’s also possible
to confirm that molecules belonging to a given group of
panallergen generate distinct clusters, as a result of the IgE
recognition of the same group of molecules, at the same time by
the same group of patients. Presumably, all the tropomyosin
sensitized patients are also exposed to pollen and food PR-10 and
profilins, but the vast majority of the cases did not recognize the
other panallergens. If such behavior is more stringent when the
IgE reactivity to tropomyosin is compared to the IgE recognition
of the plant-derived molecules, the same finding is less obvious
Figure 4. Supervised two-way hierarchical clustering analysis
of panallergen IgE values. Subjects had at least one IgE-positive
result to the panallergens under study. Allergens are reported on the y-
axis, subjects on the x-axis. Black to dark red scale corresponds to IgE
values from negative to strongly positive. Further explanations are in
the ‘Methods’ section. Panel A: Profilins; Panel B: PR-10; Panel C:
Tropomyosins.
doi:10.1371/journal.pone.0024912.g004
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possible role of HLA association in the mechanism of IgE response
is not fully understood, further investigations of the immune
mechanisms at the level of allergen-specific T cells and TCR-
MHC/peptide interactions, could identify the MHC restriction
elements capable of determine the preferential recognition of a
given panallergen group instead of another. In absence of a
genetically driven mechanism and in the light of IgE recognition of
conformational epitopes, new hypotheses should be made to
explain our findings.
Furthermore, as in the case of profilin IgE sensitization, molecules
not commonly found in the environment such as Hev b 8, hardly
found in latex gloves [27], or Mer a 1, Mercurialis annua pollen is rarely
found in the atmosphere [28], turned out to be the most frequently
recognized by patients’ IgE, most likely primarily sensitized by other
profilins. Such findings would suggest to carefully considering a
molecule as the primary sensitizer merely on the basis of its higher or
morefrequentIgEreactivity.Inthespecificcases,latexandMercurialis
profilins could act just as the best ‘‘profilin’’ reagents for specific IgE
detection among the many profilins already identified. Better
conclusions on this issue could be drawn when some profilins, like
Cuc m 2, the muskmelon profilin, commonly causing patients’
reported symptoms [29], will be available for testing. Such
observation can apply also to PR-10, as far as patients in the
geographical area under consideration are not exposed to birch
pollen [30], whereas IgE recognition of tested tropomyosins does not
seem to suggest any leading role in either a molecule as sensitizer or
just as the best reagent to detect group-related specific IgE. As in part
already reported for the studied panallergens and other allergenic
groups [31–33], in the case of profilin and PR-10, IgE co-recognition
of allergens seems not to be as obvious as it should be from their
sequence homology and structure similarity.
Discovering that the production of IgE is preferentially addressed
to a panallergen rather than another is relevant also considering the
different clinical phenotypes that these molecules could determine.
Clinical reactions of panallergens, in fact, might range from very
mild symptoms in the case of profilin reactivity [34,35], to mild or
sometimes severe symptoms if PR-10 molecules are involved
[36,37], to often severe reactions when IgE reactivity is directed
to other panallergens, such as lipid transfer proteins [38,39]. The
preferential IgE recognition of the panallergens would ease the
clinical approach to patients sensitized to one or another group.
Another topic addressed by our study is represented by the
possibility to evaluate the IgE reactivity to several representative
molecules within each group of panallergens by means of the
microarray [40]. In fact, the IgE epitope recognition of
homologous molecules, within a given group of panallergens,
could be the result of the somatic hyper-mutation and affinity
maturation after the initial IgE recognition of the primary
sensitizer as determined by the patient’s different environmental
exposure [41,42]. As shown in Figure 3, a significant relationship
within every single group of molecules was clearly shown, as the
consequence of an IgE co-recognition of all the homologous
molecules belonging to the given panallergen group [43]. At the
same time, different clusters of patients could be identified on the
basis of the diversity of IgE recognition within every single group
of panallergen (Figure 4). For instance, in the case of PR-10, two
distinct subsets of patient could be identified: those IgE reactive to
pollen-derived molecules (Bet v 1, Cor a 1 or Aln g 1) and those
also reactive to food-derived PR-10 molecules (Dau c 1, Api g 1 or
Mal d 1) (Figure 4). Similarly, in the case of tropomyosin reactivity,
two distinct subsets of patients could be identified, the first reactive
to Hel as 1 and Per a 7, and the other reactive to all the other
tropomyosins. As a consequence, the presence of distinct
representatives of a given group of panallergen represents an
added value of the microarrayed system for the evaluation of IgE
reactivity: it gives higher consistency to obtain more reliable results
and could add further information on the hypothetical sensitizer in
a given group of patients (Figure 3 and 4). All findings reported
from using different analytical approaches require further
evaluation using wet lab experimental studies using the same
microarray-based technique, as already reported for another
panallergen group, namely the lipid transfer proteins [44–46].
Overall, allergy diagnosis based on allergenic molecules is
crucial for a correct evaluation of patients sensitized to panaller-
gens. Molecular analysis represent the only way to establish the
presence of new profiles represented by profilin, tropomyosin or
PR-10 reactivity, conditions that are addressed to a preferential
recognition of one panallergen, in the vast majority of cases, as
suggested by our observations.
In conclusion, protein microarray techniques applied in allergy
diagnosis allow the identification of several IgE reactivity patterns
and possibly could lead to a better knowledge of the relationship
between basic immunological mechanisms and clinical symptoms.
We would put much emphasis on the opportunity that micro-
technologies give us to broad our allergy testing and, at the same
time, get detailed and in deep views of unselected patient’s IgE
immune recognition [7].
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